Evidence map›Paper›PMID 42101026›Full record

ArticleSexual and reproductive health matters2025

Declines in HIV testing and diagnoses: a policy analysis of the 2019 Title X federal regulations on family planning clinics.

Jennifer Sherwood, Nathan Roberson, Deborah Stenoien, Elise Lankiewicz, Brian Honermann, Greg Millett

Abstract read
In one paragraph

Article in Sexual and reproductive health matters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer SherwoodDirector of Research, Public Policy, amfAR The Foundation for AIDS Research, Washington, DC, USA.ORCID 0000-0003-2814-1684
Nathan RobersonConsultant, Public Policy Office, amfAR The Foundation for AIDS Research, Washington, DC, USA.
Deborah StenoienPublic Policy Fellow, Public Policy Office, amfAR The Foundation for AIDS Research, Washington, DC, USA.
Elise LankiewiczPolicy Associate, Public Policy Office, amfAR The Foundation for AIDS Research, Washington, DC, USA.
Brian HonermannDeputy Director, Public Policy Office, amfAR The Foundation for AIDS Research, Washington, DC, USA.
Greg MillettVice President and Director, Public Policy Office, amfAR The Foundation for AIDS Research, Washington DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2019 the Trump administration instituted a federal regulation (hereinafter the Policy) requiring that Title X family planning clinics have financial and physical separation of abortion services from other health services, and prohibited abortion referrals. In response, 32% (1,280) of Title X funded sites left the programme nationally. Our analysis connects public data from Title X Family Planning Reports (2016-2021) and CDC surveillance reports (2016-2021), to examine the Policy's impact on: (1) HIV testing at Title X clinics by region, and (2) the proportion of a region's total HIV diagnoses at Title X clinics. We use mixed multivariable linear regression modelling to examine interactions between "high" regional-level Policy exposure (defined as >25% Policy-related clinic withdrawal from the programme) and pre- and post-Policy implementation for HIV outcomes. Interaction models showed that while in effect the Policy resulted in 69,626 fewer HIV tests (95% CI -108,893 to -30,359

Indexed as

Ambulatory Care FacilitiesFamily Planning ServicesHealth PolicyHIV InfectionsHIV TestingAbortion, InducedFemaleHumansUnited Statesfamily planningHIVsexual and reproductive health policyTitle X

Identifiers

PMID42101026
PMCPMC13248498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.